Harvard Bioscience Inc. logo

Harvard Bioscience Inc.

HBIO | NASDAQ
Chart Builder DCF Calculator
$8.90
+$0.10 (+1.14%)
At close: Oct 30, 2026, 4:00 PM ET
$8.90
$0.00 (0.00%)
After-hours: Oct 30, 2026, 7:30 PM ET
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
-56.7M -12.41M -3.42M -9.52M -288K -7.81M
Depreciation & Amortization
-4.93M 7.16M 7M 7.58M 7.62M 7.63M
Stock-Based Compensation
-1.67M 4.34M 5M 4.41M 4.17M 3.65M
Other Working Capital
1.36M 940K 2.79M -917K -2.49M 77K
Other Non-Cash Items
64.3M 1.92M 509K -3.62M 280K 1.9M
Deferred Income Tax
50K 363K 336K -414K -330K -143K
Change in Working Capital
5.67M 65K 4.6M 2.72M -10.19M 4.11M
Operating Cash Flow
6.73M 1.44M 14.03M 1.15M 1.26M 9.33M
Capital Expenditures
-1.11M -3.26M -2.31M -1.59M -1.2M -1.15M
Cash Acquisitions
n/a n/a 512K n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 1.92M n/a n/a n/a n/a
Other Investing Acitivies
-605K -619K -523K n/a -150K -250K
Investing Cash Flow
-1.86M -1.34M -1.8M -1.59M -1.35M -1.4M
Debt Repayment
-1.18M 227K -10.54M -1.79M 50K -6.9M
Common Stock Repurchased
n/a n/a n/a -1.63M n/a -1.14M
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-156K -358K -1.59M 577K -3.62M 70K
Financial Cash Flow
-1.29M -131K -12.13M -2.84M -252K -7.97M
Net Cash Flow
4.51M -175K -225K -3.31M -496K -18K
Free Cash Flow
5.62M -1.82M 11.72M -438K 67K 8.18M
Adj. Free Cash Flow
7.29M -6.16M 6.72M -4.85M -4.1M 4.53M
Maintenance CapEx
-1.11M -3.26M -2.31M -1.59M n/a -1.15M
Growth CapEx
n/a n/a n/a n/a -1.2M n/a
Owner Earnings
5.62M -1.82M 11.72M -438K 1.26M 8.18M

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.